Sphingosine kinase 2 inhibitor for treating coronavirus infection

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11364227
APP PUB NO 20220031682A1
SERIAL NO

17502932

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The disclosure is directed to ABC294640, as free base or as salts thereof, in preparing medicines for treating coronavirus infection or preventing diseases caused by coronavirus infection, and a medicine for preventing coronavirus infection or preventing diseases caused by coronavirus infection.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • REDHILL BIOPHARMA LTD.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ben-Asher, Dror Tel-Aviv, IL 16 23
Fathi, Reza Oradell, US 51 159

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Dec 21, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 21, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 21, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00